The evidence for β blockers in heart failure -: Equals or surpasses that for angiotensin converting enzyme inhibitors

被引：70
|
作者：
Cleland, JGF [1 ]
McGowan, J
Clark, A
Freemantle, N
机构：
[1] Castle Hill Hosp, Dept Cardiol, Hull HU16 5JQ, N Humberside, England
[2] Univ York, Ctr Hlth Econ, Med Evaluat Grp, York YO10 5DD, N Yorkshire, England
来源：
BRITISH MEDICAL JOURNAL | 1999年 / 318卷 / 7187期
关键词：
D O I：
10.1136/bmj.318.7187.824
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：824 / 825
页数：2
相关论文
共 50 条
  • [21] Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis
    Khan, Muhammad Shahzeb
    Fonarow, Gregg C.
    Ahmed, Ali
    Greene, Stephen J.
    Vaduganathan, Muthiah
    Khan, Hassan
    Marti, Catherine
    Gheorghiade, Mihai
    Butler, Javed
    CIRCULATION-HEART FAILURE, 2017, 10 (08)
  • [22] Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure
    Edoardo Bertero
    Roberta Miceli
    Alessandra Lorenzoni
    Manrico Balbi
    Giorgio Ghigliotti
    Francesco Chiarella
    Claudio Brunelli
    Francesca Viazzi
    Roberto Pontremoli
    Marco Canepa
    Pietro Ameri
    Internal and Emergency Medicine, 2019, 14 : 1083 - 1090
  • [23] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease
    Berger, Alan K.
    Duval, Sue
    Manske, Connie
    Vazquez, Gabriela
    Barber, Cheryl
    Miller, Leslie
    Luepker, Russell V.
    AMERICAN HEART JOURNAL, 2007, 153 (06) : 1064 - 1073
  • [24] Use or nonuse of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients hospitalized for acute heart failure
    Yoshikawa, Y.
    Tamaki, Y.
    Yaku, H.
    Yamamoto, E.
    Ozasa, N.
    Inuzuka, Y.
    Morimoto, T.
    Inoko, M.
    Nakagawa, Y.
    Kato, T.
    Kimura, T.
    EUROPEAN HEART JOURNAL, 2017, 38 : 909 - 909
  • [25] Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure: invasive hemodynamic parameters and clinical outcomes
    Lo, Kevin Bryan
    Toroghi, Hesam Mostafavi
    Salacup, Grace
    Jiang, Jiahui
    Bhargav, Ruchika
    Quintero, Eduardo
    Balestrini, Kira
    Shahzad, Anum
    Mathew, Roy O.
    McCullough, Peter A.
    Rangaswami, Janani
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2021, 22 (01) : 199 - 206
  • [26] Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure
    Bertero, Edoardo
    Miceli, Roberta
    Lorenzoni, Alessandra
    Balbi, Manrico
    Ghigliotti, Giorgio
    Chiarella, Francesco
    Brunelli, Claudio
    Viazzi, Francesca
    Pontremoli, Roberto
    Canepa, Marco
    Ameri, Pietro
    INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (07) : 1083 - 1090
  • [27] Continuation of Angiotensin Converting Enzyme Inhibitors in Acute Heart Failure
    AlHabeeb, Waleed
    Hayajneh, Ahmad
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 2041 - 2045
  • [28] Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension
    Ritter, J. M.
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
  • [29] META ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITHOUT HEART FAILURE
    Savarese, G.
    Costanzo, P.
    Cleland, J. G. F.
    Vassallo, E.
    Ruggiero, D.
    Rosano, G.
    Perrone-Filardi, P.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2013, 9 (02) : 188 - 200
  • [30] Angiotensin converting enzyme inhibitors and angiotensin receptor blockers used in combination with spironolactone and the risk of admission hyperkalemia in heart failure patients
    Ewen, Edward F.
    Mehring, Collette
    Corbo, Terri
    Kolm, Paul
    Jurkovitz, Claudine
    CIRCULATION, 2006, 113 (21) : E803 - E803
12345